08:15 AM EDT, 08/08/2025 (MT Newswires) -- CG Oncology ( CGON ) reported a Q2 loss Friday of $0.54 per diluted share, compared with a loss of $0.28 a year earlier.

Analysts polled by FactSet expected a loss of $0.46.

The company did not report any revenue for the quarter ended June 30. It reported license and collaboration revenue of $111,000 a year earlier.

Analysts polled by FactSet expected $100,000.